Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
RA ›
RAKOSPEC
Trademark search for:
RAKOSPEC
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-11-18 — Application filed
2020-11-21 — Application filed
2021-01-07 — Attorney/dom.rep.revoked and/or appointed
2021-01-07 — Teas change of correspondence received
2021-01-07 — Teas revoke/app/change addr of atty/dom rep received
2021-01-07 — Teas withdrawal of attorney received-firm retains
2021-01-22 — Application filed
2021-03-16 — Attorney/dom.rep.revoked and/or appointed
2021-03-16 — Teas change of owner address received
2021-03-16 — Teas change of correspondence received
2021-03-16 — Applicant/correspondence changes (non-responsive) entered
2021-03-16 — Teas revoke/app/change addr of atty/dom rep received
2021-03-16 — Teas withdrawal of attorney received-firm retains
2021-04-29 — Approved for pub - principal register
2021-04-29 — Assigned to examiner
2021-05-12 — Notification of notice of publication e-mailed
2021-06-01 — Published for opposition
2021-06-01 — Official gazette publication confirmation e-mailed
2021-07-27 — Noa e-mailed - sou required from applicant
2022-02-28 — Application abandoned
2022-02-28 — Application abandoned
2022-02-28 — Final status recorded
Owner Information
Sumitomo Dainippon Pharma Oncology, Inc.
Cambridge , MA
Sumitomo Dainippon Pharma Oncology, Inc.
Cambridge , MA
Correspondent
John V. Hobgood, Esquire WILMER CUTLER PICKERING HALE AND DORR LLP 60 STATE STREET BOSTON, MA 02109 UNITED STATES
Filing Details
Filing Date:
2020-11-18
Status Date:
2022-02-28
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.